SMAD2 antibody | antibody review based on formal publications

ExactAntigen

SMAD2 antibody | antibody review based on formal publications

SMAD2 antibodies
This is a review about SMAD2 antibodies, based on 40 published articles using SMAD2 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited SMAD2 antibody.

all

Sigma-Aldrich search Sigma-Aldrich SMAD2 products
ih	Sigma α-smooth muscle actin (clone 1A4) antibody was used in immunocytochemistry to indicate potential therapeutic use of PDGF-D or PDGFRß inhibitors to block human renal cell carcinoma tumor progression. to the paper

Cell Signaling Technology search Cell Signaling Technology SMAD2 products
wb	Cell Signaling Technology rabbit polyclonal anti-phospho-Smad2 antibody was used in western blot to study the role for the interaction of Nodal with GDF1 in long-range action of Nodal in mice. to the paper
wb	Cell Signaling Technology anti-phospho-Smad2 and anti-Smad2 antibody was used in western blot to study the role of acetylation, one of the main post-translational regulatory mechanisms, in regulating Fli1 activity in human dermal fibroblast. to the paper
wb	Cell Signaling Technologies antiphospho-Smad2 antibody was used in western blot to study the role of disintegrin and metalloproteinase ADAM12 in TGF-beta signaling through interaction with the type II receptor. to the paper
ih	Cell Signaling phospho-Smad2 antibody was used in immunohistochemistry to study the role of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. to the paper
ih	Immunohistochemistry was performed using a polyclonal antibody recognizing pSmad2 (Cell Signaling Technology, Danvers). to the paper
wb	phospho-Smad2 antibody was used in western blot to study phospholation of Smad2 by caALK5. to the paper
wb	Cell Signaling rabbit polyclonal anti-phospho-Smad2/3 antibody was used in western blot to study expression of nodal, lefty-A, and lefty-B in undifferentiated human embryonic stem cells. to the paper
ih, wb	Cell Signaling Technology anti-phospho-Smad2 antibody was used in immunohistochemistry and western blot to study the role for TGF-β/Smad3 in the pathogenesis of scleroderma in a mouse model of scleroderma. to the paper
wb	Cell Signaling anti-phospho-Smad2 antibody was used in western blot to study the role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. to the paper
wb	Cell Signaling Technology anti-phospho-Smad2 antibody was used in western blot to detect phospho-Smad8 in human fibroblastic cells infected with recombinant adenovirus vectors carrying ALK5CA. to the paper
ih, wb	Cell Signaling Biotechnologies anti-phospho-Smad2 antibody was used in western blot and immunohistochemistry to detect phospho-Smad2 in ESC-derived endothelial cells from mouse. to the paper
wb	Cell Signaling phospho-Smad2 antibody was used in western blot to study Cripto roles in tumor cell growth in vivo. to the paper
ih, wb	Cell Signaling anti-phospho-Smad2 antibody was used in western blot and immunohistochemistry to study that transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. to the paper
wb	New England Biolabs monoclonal anti-Smad2 antibody was used in transformed primary human embryonal kidney cells and in western blot to study the effect of transforming growth factor- 1 mutations on the action of TGF- 1 in vitro. to the paper

BIOMOL International search BIOMOL International SMAD2 products
wb	Biomol anti-phospho-Smad2 (Ser465/Ser467) antibody was used in human pancreatic cancer cell lines PANC-1 and BxPC-3 and the osteoblastic osteosarcoma cell line MG-63 and in western blot to study the involvement of Smad proteins in the TGF-beta control of BGN and SLRP gene expression. to the paper

Santa Cruz Biotechnology search Santa Cruz Biotechnology SMAD2 products
ip, wb	Santa Cruz Biotechnology anti-Smad2 antibody was used in western blot and immunoprecipitation to investigate the regulation and mechanism of renal SnoN expression in vivo. to the paper
wb	Santa Cruz Biotechnology rabbit anti-phospho-Smad2/3 (Ser433/Ser435) antibody was used in western blot to hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells. to the paper
ih, wb	Santa Cruz Biotechnology anti-Smad2/3 and anti-Phospho-Smad2/3 antibodies were used in western blot to study chondrogenesis Induction by Smad3. to the paper
ic	Santa Cruz Biotechnology mouse anti-Smad1/2/3 (H-2) antibody was used in immunocytochemistry to study the role of internalization in transforming growth factor beta 1-induced smad2 association with smad anchor for receptor activation (SARA) and smad2-dependent signaling in human mesangial cells. to the paper
wb	Santa Cruz Smad2 antibody was used in western blot to study the pituitary prolactin expression and cell growth inhibited by activin. to the paper
wb	Santa Cruz Biotechnology Inc antibody for Smad2/Smad3 was used in blocking experiment to study the impaired Smad7-Smurf–mediated negative regulation of TGF-ß signaling in scleroderma fibroblasts. to the paper
wb	Santa Cruz Biotechnology anti-Smad2 antibody was used in western blot to study the effect of Smad3 on transforming growth factor-ß–induced alpha-smooth muscle actin expression in rat fibroblasts. to the paper
wb	Santa Cruz Biotechnology anti-phospho-Smad2 antibody was used in western blot to study that transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. to the paper
emsa	Santa Cruz anti-Smad2/3 (N-19) antibody was used in EMSA to study the inhibitory effect of TGFbeta on adipocyte differentiation through Smad3 interacting with C/EBP and Repressing C/EBP transactivation function. to the paper
ip, wb	Santa Cruz Biotechnology polyclonal anti-Smad2/3 antibody(catalog no. sc-6032) was used in western blot and immunoprecipitation to study the role for the interaction of up-regulated transcriptional repressors SnoN and Ski with Smad proteins and TGF beta in liver regeneration in mice live cells. to the paper
ip	Santa Cruz Biotechnology rabbit polyclonal antibody against Smad2 was used in immunoprecipitation to examine the influence of transforming growth factor (TGF) -ß1 on proximal tubular epithelial cell-cell interaction, with particular emphasis on the regulation of adherens junction complex formation. to the paper
ih, wb	Santa Cruz Biotechnology Smads2 antibody was used in western blot and immunohistochemistry to demonstrate that alterations in the Smad pathway is responsible for TGF-beta hyperresponsiveness. to the paper
ih, wb	Santa Cruz Biotechnology anti-Smad2/3 antibody was used in western blot and immunohistochemistry to address whether and how TGF-beta signaling becomes disrupted during human breast cancer development in vivo. to the paper
wb	Santa Cruz Biotechnology antibody to Smad2 was used in western blot to detect Smad2 in human HD3 and U9 HT29 colon carcinoma sublines. to the paper

Invitrogen search Invitrogen SMAD2 products
wb	Biosource rabbit polyclonal anti-phospho-Smad2 antibody was used in western blot to study the role for expression and secretion of macrophage-derived galectin-3 in promotion of renal fibrosis in mouse tissue. to the paper
wb	Zymed Laboratories Smad2 antibody was used in western blot to study the role of disintegrin and metalloproteinase ADAM12 in TGF-beta signaling through interaction with the type II receptor. to the paper
wb	Biosource anti-phospho-Smad2 (Ser465/467) antibody was used in western blot to study endofin as a Smad anchor for receptor activation in BMP signaling. to the paper
ic	Zymed Laboratories rabbit anti-Smad2/Smad3 antibody was used in immunocytochemistry to study COLO-357 cell growth inhibition by TGF beta1. to the paper
wb	Smad2 antibody was used in western blot to study activation of Smad2 by ALK5. to the paper
wb	Zymed Laboratories anti-Smad2 antibody was used in western blot to study the role for TGF-β/Smad3 in the pathogenesis of scleroderma in a mouse model of scleroderma. to the paper
wb	Zymed Laboratories anti-phospho-Smad2 rabbit polyclonal antibody was used in western blot to study the role of TGF- signaling in the phosphorylation of Smad2 and Smad3. to the paper
wb	Zymed Laboratories SMAD2 antibody was used in western blot to demonstrate that SMAD2 and SMAD7 were involved in the post-translational regulation of Muc4. to the paper
wb	Zymed Laboratories Inc anti-total Smad2 antibody was used in human pancreatic cancer cell lines PANC-1 and BxPC-3 and the osteoblastic osteosarcoma cell line MG-63 and in western blot to study the involvement of Smad proteins in the TGF-beta control of BGN and SLRP gene expression. to the paper
ip, wb	Zymed Laboratories Inc. anti-human Smad2 antibody (LPB2) was used in human T47D and MCF-7 cells and in immunoprecipitation and western blot to study a signaling pathway for IGFBP-3 from a cell surface receptor to nuclear transcriptional activity. to the paper
wb	Zymed Laboratories anti-total Smad2 antibody was used to Smad, ERK1/2, and p38 mitogen-activated protein kinase pathway cross-talka in chondrogenic ATDC5 cells. to the paper

BD Biosciences search BD Biosciences SMAD2 products
wb	BD Transduction Laboratories anti-Smad2/3 antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1. to the paper
wb	Transduction Laboratories anti-SMAD2 antibody (catalog no. S66220) was used in cultured human cell lines and in western blot to study the effect of gadd45β3' enhancer on SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor β. to the paper
ip, wb	Transduction Laboratories anti-Smad2 antibody was used in western blot and immunoprecipitation to study Smad3 activation in the transforming growth factor beta signaling pathway. to the paper
ic	Transduction Laboratories anti-Smad2/3 antibody was used in immunocytochemistry to Smad, ERK1/2, and p38 mitogen-activated protein kinase pathway cross-talka in chondrogenic ATDC5 cells. to the paper

Millipore search Millipore SMAD2 products
wb	Upstate Biotechnologies phospho-Smad2 antibody was used in western blot to study COLO-357 cell growth inhibition by TGF beta1. to the paper
ih	Upstate anti-Smad2/3 antibodies were used in immunohistochemistry to study chondrogenesis Induction by Smad3. to the paper
wb	Upstate Biotechnology rabbit polyclonal anti-Smad2/3 antibody was used in western blot to study expression of nodal, lefty-A, and lefty-B in undifferentiated human embryonic stem cells. to the paper
wb	Upstate Biotechnology phospho-Smad2 antibody was used in western blot to study the pituitary prolactin expression and cell growth inhibited by activin. to the paper
wb	Upstate Biotechnology Inc antibody for phospho-Smad2 was used in western blot to study the impaired Smad7-Smurf–mediated negative regulation of TGF-ß signaling in scleroderma fibroblasts. to the paper
wb	Upstate Biotechnology anti-phospho-Smad2 (Ser465/Ser467) antibody was used in human pancreatic cancer cell lines PANC-1 and BxPC-3 and the osteoblastic osteosarcoma cell line MG-63 and in western blot to study the involvement of Smad proteins in the TGF-beta control of BGN and SLRP gene expression. to the paper
wb	Upstate Biotechnology polyclonal anti-phospho-Smad2 antibody(catalog no. 06-829) was used in western blot to study the role for the interaction of up-regulated transcriptional repressors SnoN and Ski with Smad proteins and TGF beta in liver regeneration in mice live cells. to the paper
ih, wb	Upstate Biotechnology phospho-Smads2 antibody was used in western blot and immunohistochemistry to demonstrate that alterations in the Smad pathway is responsible for TGF-beta hyperresponsiveness. to the paper
wb	Upstate Biotechnology anti-phospho-Smad2 antibody (phosphorylated C-terminal) was used to Smad, ERK1/2, and p38 mitogen-activated protein kinase pathway cross-talka in chondrogenic ATDC5 cells. to the paper

ROCHE MOLECULAR BIOCHEMICALS
wb	Roche Molecular Biochemicals rabbit anti-phospho-Smad2 (Ser-465/467) antibody was used in human breast tumor cells (MDA-MB-231 cells) and in western blot to study the effect of hyaluronan on the interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. to the paper

AUTOGEN BIOCLEAR
emsa, ip	Autogen Bioclear goat anti-human Smad2 antibody was use in western blot to study TGF-beta1 signaling. to the paper

MICHAEL REISS(UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY)
ih, wb	Michael Reiss(University of Medicine and Dentistry of New Jersey) polyclonal rabbit anti-phospho-Smad2 antibody was used in western blot and immunohistochemistry to address whether and how TGF-beta signaling becomes disrupted during human breast cancer development in vivo. to the paper

Articles Reviewed
1:	Neil C Henderson et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. 2008
2:	Weibin Shi et al. Endofin acts as a Smad anchor for receptor activation in BMP signaling. 2007
3:	Yoshihide Asano et al. Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. 2007
4:	Chinatsu Tanaka et al. Long-range action of Nodal requires interaction with GDF1. 2007
5:	Lanying Song et al. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. 2007
6:	Azeddine Atfi et al. The disintegrin and metalloproteinase ADAM12 contributes to TGF-beta signaling through interaction with the type II receptor. 2007
7:	Ruoyun Tan et al. Downregulation of SnoN expression in obstructive nephropathy is mediated by an enhanced ubiquitin-dependent degradation. 2006
8:	Jennifer P Habashi et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. 2006
9:	Hendrik Ungefroren et al. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. 2005
10:	Lei Xu et al. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model. 2005
11:	Takayuki Furumatsu et al. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. 2005
12:	Xiao Liang Zhang et al. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. 2005
13:	Constance E Runyan et al. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. 2005
14:	Shuanhu Zhou et al. Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling. 2005
15:	Nichole Boyer Arnold et al. Smad7 abrogates transforming growth factor-beta1-mediated growth inhibition in COLO-357 cells through functional inactivation of the retinoblastoma protein. 2005
16:	Yoshihide Asano et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. 2004
17:	Hiroaki Seto et al. Distinct roles of Smad pathways and p38 pathways in cartilage-specific gene expression in synovial fibroblasts. 2004
18:	Daniel Besser et al. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. 2004
19:	Michael B Major et al. Identification of a gadd45beta 3' enhancer that mediates SMAD3- and SMAD4-dependent transcriptional induction by transforming growth factor beta. 2004
20:	Gabriella Lakos et al. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. 2004
21:	Annie Lacerte et al. Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. 2004
22:	Mario Schiffer et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. 2004
23:	Lisa Choy et al. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. 2003
24:	Celine Prunier et al. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation. 2003
25:	Heather B Adkins et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. 2003
26:	Tetsuro Watabe et al. TGF-beta receptor kinase inhibitor enhances growth and integrity of embryonic stem cell-derived endothelial cells. 2003
27:	Biao Hu et al. Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. 2003
28:	Dirk Haller et al. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. 2003
29:	Katrien Janssens et al. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. 2003
30:	Pedro Soto et al. SMAD2 and SMAD7 involvement in the post-translational regulation of Muc4 via the transforming growth factor-beta and interferon-gamma pathways in rat mammary epithelial cells. 2003
31:	Marina Macias-Silva et al. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. 2002
32:	Ya Chung Tian et al. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. 2002
33:	Chunming Dong et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. 2002
34:	Susan Fanayan et al. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. 2002
35:	Wen-Bin Chen et al. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. 2002
36:	Wen Xie et al. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. 2002
37:	Lilly Y W Bourguignon et al. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. 2002
38:	Zhongfa Yan et al. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1. 2002
39:	M Furuhashi et al. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. 2001
40:	H Watanabe et al. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. 2001

home | browse | about